was a student registered nurse anesthetist at Virginia Commonwealth University in Richmond, Virginia, at the time he wrote this article. He graduated in December 2019. He earned his BSN at Georgetown University in Washington, DC, in 2013.
AANA J. 2021 Feb;89(1):77-86.
Opioids are a mainstay in the modern practice of anesthesia and perioperative pain management. However, due to the crisis surrounding opioid use and abuse, as well as the undesirable side effects that occur with normal use, anesthesia providers are searching for ways to curtail perioperative opioid use. The advent of various analgesic adjuncts such as dexmedetomidine has opened new avenues for multimodal analgesic approaches to perioperative pain management. A review of current research focused on these analgesic adjuncts and the drawbacks of opioid use reveals increased understanding and complexity of the physiology of pain, its treatment, and our understanding of pharmacologic mechanisms of action of analgesics. This course will examine the current limitations of opioids, provide a brief overview of the physiology of pain, and discuss the pharmacologic mechanism of action of dexmedetomidine and patient populations in which its use might be advantageous.
阿片类药物是现代麻醉和围手术期疼痛管理的主要手段。然而,由于阿片类药物使用和滥用所带来的危机,以及正常使用时出现的不良副作用,麻醉师正在寻找减少围手术期阿片类药物使用的方法。各种镇痛辅助药物的出现,如右美托咪定,为围手术期疼痛管理的多模式镇痛方法开辟了新途径。对当前研究的回顾集中在这些镇痛辅助药物和阿片类药物使用的缺点上,揭示了对疼痛生理学、治疗以及我们对镇痛药作用机制的理解的增加和复杂性。本课程将探讨阿片类药物的当前局限性,简要概述疼痛生理学,并讨论右美托咪定的药理作用机制以及可能受益于其使用的患者人群。